🏛 Part of the "health" topic shelf →

How Should We Evaluate Vitamins and Supplements? An Evidence-Based Reading of Fish Oil, Vitamin D, and Red Yeast Rice
The efficacy and safety of supplements cannot be judged solely by claims that they are “natural,” “water-soluble,” or “supported by research.” We must first ask whether the user has a deficiency, whether the studied product and dose match the one being taken, whether the clinical endpoint truly matters, and whether the evidence comes from randomized trials or observational studies. Professor Ching-Shun Lin has long cautioned the public against exaggerated marketing, and a large body of literature supports this core position. Later evidence also shows, however, that a small number of specific ingredients, formulations, or populations may derive limited benefit; supplements should not all be treated alike.
Vitamins and Supplements: Ask About Need First, Then Evidence
The Bottom Line in One Sentence
For generally healthy adults with adequate nutrition, supplements usually cannot replace a balanced diet and have not been shown to prevent cardiovascular disease, cancer, or death across the population. People with deficiencies, high-risk groups, and specific prescription formulations must be assessed individually, however; “usually unnecessary” must not be rewritten as “unnecessary for everyone.” PMID: 35727272
What Did Professor Lin’s Original Article Warn About?
Professor Ching-Shun Lin has long opposed marketing nutrients as cure-alls. He also reminds readers not to infer that a product must be effective and safe merely because its label says “natural,” because a vitamin is water-soluble, or because an advertisement cites a study. That core position remains sound today. In generally healthy adults without a known deficiency, randomized trials and systematic reviews show that most vitamin and mineral supplements provide little or no benefit in preventing major chronic diseases or death, while some high-dose products may cause harm. PMID: 35727272
“Food first,” however, does not mean rejecting every supplement. The literature recognizes appropriate supplementation for nutritional deficiencies, malabsorption, special physiological stages, and other high-risk states. The key question is therefore not whether a supplement is categorically “good or bad,” but who is using it, why it is being used, which formulation is involved, and whether the intended outcome is a laboratory value or a health result that patients can actually experience. PMID: 41728409
Fish Oil and omega-3: Ordinary Supplements Are Not Prescription-Grade EPA
Professor Lin’s skepticism about fish-oil marketing rests on a strong evidentiary foundation. Large meta-analyses have not shown that ordinary omega-3 supplements significantly reduce deaths from coronary heart disease or major vascular events. The EPA and DHA content of retail supplements also varies widely, and health claims on a label cannot substitute for evidence from clinical outcomes. PMID: 29387889
The literature has since evolved, however, so a lack of preventive benefit from ordinary fish-oil supplements must not be extended into the claim that every omega-3 formulation is ineffective. A specific high-dose, prescription-grade formulation of purified EPA may benefit selected populations at cardiovascular risk; that is a different question from the use of ordinary retail fish oil. The boundary now justified by scientific progress is to reject the blanket marketing of retail fish oil as essential for heart protection while preserving room for physicians to prescribe specific formulations for appropriate indications. PMID: 42070013
Nor should conclusions about fish oil be drawn from headlines about “biological aging” alone. Subsequent research found small signals of an omega-3 effect on some DNA methylation-based biological age clocks, but this line of research has not shown that it reverses actual aging, extends life, or improves healthspan. A change in a biomarker does not mean that a person has genuinely become younger in clinical terms. PMID: 39900648
Vitamin D: Raising a Blood Level Does Not Mean Preventing Disease Broadly
Vitamin D has hormone-like properties, and serum 25(OH)D is commonly used as a marker of vitamin D status. The optimal target for general disease prevention remains unclear, however. Current guidelines do not recommend routine testing in people without an established indication for testing or treatment, and a single low result cannot be interpreted to mean that everyone needs supplementation. PMID: 38828931
Randomized trials in general middle-aged and older populations have not shown that routine vitamin D supplementation reduces invasive cancer or major cardiovascular events. Among broadly selected populations not specifically recruited for deficiency or bone disease, its overall effects on fractures and falls are also small or clinically insignificant. These conclusions do not apply to people with a confirmed deficiency, rickets, specific bone diseases, or other clear medical indications. PMID: 30415629
The idea that “a little more cannot hurt” is likewise false. Excess vitamin D can cause hypercalcemia and serious complications, and one strategy using a very high annual dose even increased falls and fractures among older women. Supplementation should therefore follow clinical indications and professional advice, not a pursuit of ever-higher blood levels or ever-larger doses. PMID: 20460620
Updates in the literature should also be stated accurately and openly. A newer large randomized trial found fewer incident autoimmune diseases in the vitamin D group. It is therefore no longer tenable to make the absolute claim that “vitamin D cannot possibly help with any autoimmune disease.” This does not mean, however, that vitamin D has become an autoimmune-disease preventive drug that everyone should take. PMID: 35082139
B Vitamins, B12, and Anti-Aging Compounds: Changing a Number Is Not the Same as Improving Health
Water solubility does not eliminate toxicity. Long-term excessive supplementation with vitamin B6 can cause sensory peripheral neuropathy, producing numbness, tingling, burning, or weakness. When several products containing B6 are taken together, the label on any single bottle is especially inadequate for assessing total exposure. PMID: 33912895
People following a vegan diet are a classic exception requiring individualized attention. When the diet is not planned properly, the risk of B12 deficiency is higher. The content and bioavailability of algae-derived sources are unreliable, so dependable fortified foods or supplements may be necessary. Professor Lin’s warning about the reliability of algae therefore deserves attention, but the advice to “avoid tablets under all circumstances” does not reflect the full body of evidence available today. PMID: 39373282
For anti-aging products such as NR and NMN, biochemical effects must likewise be separated from clinical effects. NR is a form of vitamin B3 and a precursor of NAD+. Human trials show increases in relevant biomarkers, but broad clinical benefits for muscle function, cognition, or anti-aging have yet to be established. The literature has advanced and now includes human studies, yet it remains insufficient to support sweeping marketing promises of “slowing aging.” PMID: 37994989
Red Yeast Rice, Herbal Products, and Adulteration: Active Ingredients Come with Quality Concerns
Red yeast rice best illustrates why “does it work?” cannot be the only question. Products containing monacolin K may lower LDL-C, so in light of current evidence, it would be incomplete to characterize every red yeast rice product as having no health effect at all. On the other hand, retail products may vary in content, be inconsistent with their labels, or contain nephrotoxic contaminants. A signal of efficacy cannot cancel out risks involving quality and safety. PMID: 41681060
Later literature on a specific red yeast rice incident in Japan further supports puberulic acid as an important causal candidate and one of the mechanisms behind kidney injury from the toxic batches. This is a clarification of a particular event made possible by scientific progress. It does not mean that every red yeast rice product has the same contamination, nor should it be read in reverse as proof that other products are therefore safe. PMID: 41732753
An herbal origin is not a seal of immunity from harm. Case reports and systematic assessments support an association between highly bioavailable turmeric supplements and acute liver injury, while high-dose green tea extracts have also produced liver-injury signals. Foods and beverages used in ordinary diets do not create the same exposure as concentrated supplements. Any evaluation must consider the ingredient, concentration, formulation, concomitant medications, and symptoms. PMID: 32656820
Dietary supplements may also contain undisclosed or unapproved pharmaceutical ingredients. The United States system relies more heavily on postmarket surveillance, and the appearance of FDA on a product does not mean its efficacy received the same premarket approval required for a drug. Claims of “officially certified efficacy” or guaranteed cures should prompt verification of the product’s actual approval status and supporting evidence. PMID: 30646238
Practical Decisions: Return the Question to Need and Outcomes
To evaluate a supplement, ask in sequence: Is there a clear deficiency or medical indication? Is the product and formulation studied the same as the one being purchased, and is the dose the same? Does the evidence come from randomized human trials? Does the reported improvement concern a laboratory number or surrogate marker, or clinical endpoints such as symptoms, hospitalization, fractures, and death? Finally, examine adverse effects, drug interactions, and product quality.
For people with adequate nutrition, a balanced diet remains the foundation, and supplements cannot repair an unhealthy lifestyle. Those with a deficiency, restricted diet, malabsorption, pregnancy or lactation, a specific disease, or prescription medications should have decisions tailored by a healthcare professional to their individual circumstances. Professor Lin’s original warning against excessive marketing should be preserved. Where the literature has advanced, the boundaries should be refined by identifying the applicable population and formulation more precisely. That is what evidence-based evaluation requires. PMID: 40900846
FAQ
- Can taking a multivitamin every day help the average person live longer?
- Current large prospective datasets do not show that daily multivitamin use lowers all-cause mortality, and observed associations cannot be treated directly as causal. PMID: 38922615
- 一般の人がマルチビタミンを毎日飲むと、寿命を延ばせますか? — 現在の大規模前向きデータでは、マルチビタミンの毎日の使用によって全死亡率が低下することは示されていません。観察された関連も、そのまま因果関係とはみなせません。PMID: 38922615
- Can taking a multivitamin every day help the average person live longer? — Current large prospective datasets do not show that daily multivitamin use lowers all-cause mortality, and observed associations cannot be treated directly as causal. PMID: 38922615
- Should fish oil be considered a heart-health supplement that everyone needs?
- No. Fish oil within the range used in ordinary supplements has not shown a clear cardiovascular benefit. Specific prescription-grade EPA and ordinary retail fish oil should be evaluated separately. PMID: 37610733
- 魚油は、誰もが必要とする心臓保護サプリメントと考えてよいですか? — いいえ。一般的なサプリメントの範囲の魚油には、明確な心血管系の利益が示されていません。特定の処方用 EPA と一般の市販魚油は分けて判断すべきです。PMID: 37610733
- Should fish oil be considered a heart-health supplement that everyone needs? — No. Fish oil within the range used in ordinary supplements has not shown a clear cardiovascular benefit. Specific prescription-grade EPA and ordinary retail fish oil should be evaluated separately. PMID: 37610733
- Does a low vitamin D level always mean supplementation is necessary?
- Not necessarily. Evidence is insufficient to determine the balance of benefits and harms of routine screening in asymptomatic adults. Supplementation decisions should consider the degree of deficiency, symptoms, diseases, and established indications. PMID: 33847711
- ビタミン D の値が低ければ、必ず補充する必要がありますか? — 必ずしもそうではありません。無症状の成人をルーチンにスクリーニングする利益と不利益については、エビデンスが不十分です。補充するかどうかは、欠乏の程度、症状、疾患、確立した適応を踏まえて判断すべきです。PMID: 33847711
- Does a low vitamin D level always mean supplementation is necessary? — Not necessarily. Evidence is insufficient to determine the balance of benefits and harms of routine screening in asymptomatic adults. Supplementation decisions should consider the degree of deficiency, symptoms, diseases, and established indications. PMID: 33847711
- Does taking more vitamin D always lead to better bone health?
- No. A specific very high annual dose increased falls and fractures; supplementation cannot be guided by the assumption that “more is better.” PMID: 20460620
- ビタミン D は、多く飲むほど骨によいのですか? — いいえ。特定の年間超高用量投与では転倒と骨折が増えました。補充を「多いほどよい」と推論することはできません。PMID: 20460620
- Does taking more vitamin D always lead to better bone health? — No. A specific very high annual dose increased falls and fractures; supplementation cannot be guided by the assumption that “more is better.” PMID: 20460620
- Because B vitamins are water-soluble, is it impossible to take a toxic amount?
- No. Excess vitamin B6 can cause sensory peripheral neuropathy. Water solubility does not make unlimited intake safe. PMID: 33912895
- ビタミン B 群は水溶性なので、多く飲んでも中毒になりませんか? — いいえ。ビタミン B6 の過剰摂取は感覚性末梢神経障害を引き起こす可能性があります。水溶性だからといって、無制限に摂取してよいわけではありません。PMID: 33912895
- Because B vitamins are water-soluble, is it impossible to take a toxic amount? — No. Excess vitamin B6 can cause sensory peripheral neuropathy. Water solubility does not make unlimited intake safe. PMID: 33912895
- Can a vegan diet rely on algae alone as a source of B12?
- Algae should not be treated as the sole reliable source. People following a vegan diet should plan for dependable fortified foods or supplements and seek assessment when needed. PMID: 39373282
- 完全菜食では、B12 を藻類だけから摂取できますか? — 藻類を唯一の信頼できる供給源と考えるべきではありません。完全菜食者は、信頼できる強化食品やサプリメントによる摂取を計画し、必要に応じて評価を受けるべきです。PMID: 39373282
- Can a vegan diet rely on algae alone as a source of B12? — Algae should not be treated as the sole reliable source. People following a vegan diet should plan for dependable fortified foods or supplements and seek assessment when needed. PMID: 39373282
- If red yeast rice may lower cholesterol, does that mean the product is safe and effective?
- That conclusion does not follow. Specific ingredients may lower LDL-C, but retail products still differ in content, labeling, contamination, and toxicity and must be evaluated individually. PMID: 34950692
- 紅麹はコレステロールを下げる可能性があるなら、製品は安全で有効ということですか? — そのようには推論できません。特定の成分は LDL-C を低下させる可能性がありますが、市販製品には含有量、表示、汚染、毒性の違いがあり、個別に評価しなければなりません。PMID: 34950692
- If red yeast rice may lower cholesterol, does that mean the product is safe and effective? — That conclusion does not follow. Specific ingredients may lower LDL-C, but retail products still differ in content, labeling, contamination, and toxicity and must be evaluated individually. PMID: 34950692
- Does an FDA label on a supplement mean its efficacy is officially certified?
- No. Dietary-supplement regulation relies more heavily on postmarket surveillance, and the letters FDA cannot substitute for drug-style premarket approval of efficacy. PMID: 42190612
- FDA と表示されたサプリメントは、公的に効果が認証されているのですか? — いいえ。栄養補助食品の規制は市販後監視への依存度が高く、FDA の文字は、医薬品のような有効性の市販前承認に代わるものではありません。PMID: 42190612
- Does an FDA label on a supplement mean its efficacy is officially certified? — No. Dietary-supplement regulation relies more heavily on postmarket surveillance, and the letters FDA cannot substitute for drug-style premarket approval of efficacy. PMID: 42190612
Source anchors
- 林慶順教授原文正本 · http://professorlin.com/2018/11/21/%e9%ad%9a%e6%b2%b9%ef%bc%8cepa-dha%ef%bc%8comega-3/
- 存證·Wayback 快照(原站消失仍可溯源) · https://web.archive.org/web/2/http://professorlin.com/2018/11/21/%e9%ad%9a%e6%b2%b9%ef%bc%8cepa-dha%ef%bc%8comega-3/
- 存證·archive.today 快照 · https://archive.ph/newest/http://professorlin.com/2018/11/21/%e9%ad%9a%e6%b2%b9%ef%bc%8cepa-dha%ef%bc%8comega-3/
- 一般成人維生素與礦物質補充的預防效益及風險 · https://pubmed.ncbi.nlm.nih.gov/35727272/
- 一般補充、缺乏與高風險族群的適用邊界 · https://pubmed.ncbi.nlm.nih.gov/41728409/
- omega-3 補充劑與心血管結局統合分析 · https://pubmed.ncbi.nlm.nih.gov/29387889/
- 特定處方級 EPA 配方的心血管證據 · https://pubmed.ncbi.nlm.nih.gov/42070013/
- omega-3 與 DNA 甲基化生物年齡時鐘 · https://pubmed.ncbi.nlm.nih.gov/39900648/
- 維他命 D 檢測與一般疾病預防指南 · https://pubmed.ncbi.nlm.nih.gov/38828931/
- 維他命 D 與癌症、重大心血管事件隨機試驗 · https://pubmed.ncbi.nlm.nih.gov/30415629/
- 年度極高劑量維他命 D 與跌倒、骨折 · https://pubmed.ncbi.nlm.nih.gov/20460620/
- 維他命 D 與自體免疫疾病發生的隨機試驗 · https://pubmed.ncbi.nlm.nih.gov/35082139/
- 過量維他命 B6 與感覺性周邊神經病變 · https://pubmed.ncbi.nlm.nih.gov/33912895/
- 全素飲食的 B12 來源與缺乏風險 · https://pubmed.ncbi.nlm.nih.gov/39373282/
- NR 補充的人體生物標記與臨床結果 · https://pubmed.ncbi.nlm.nih.gov/37994989/
- 含 monacolin K 產品與 LDL-C · https://pubmed.ncbi.nlm.nih.gov/41681060/
- puberulic acid 與特定紅麴事件腎損傷機制 · https://pubmed.ncbi.nlm.nih.gov/41732753/
- 薑黃補充劑相關急性肝損傷 · https://pubmed.ncbi.nlm.nih.gov/32656820/
- 膳食補充劑未核准藥物成分與監測 · https://pubmed.ncbi.nlm.nih.gov/30646238/
- 營養充足者、缺乏者與補充適應情況 · https://pubmed.ncbi.nlm.nih.gov/40900846/
- 綜合維他命使用與全因死亡率 · https://pubmed.ncbi.nlm.nih.gov/38922615/
- 市售魚油健康聲稱、劑量差異與臨床證據 · https://pubmed.ncbi.nlm.nih.gov/37610733/
- 無症狀成人維他命 D 缺乏篩檢建議 · https://pubmed.ncbi.nlm.nih.gov/33847711/
- 市售紅麴產品污染與標示問題 · https://pubmed.ncbi.nlm.nih.gov/34950692/
- 美國膳食補充劑的上市後監管制度 · https://pubmed.ncbi.nlm.nih.gov/42190612/
- 存證·自存副本(原站消失仍可溯源) · https://km.idaeo.ai/archive/professorlin/13828.html
- 存證·自存副本(原站消失仍可溯源) · https://km.idaeo.ai/archive/professorlin/7820.html
Cite this article
TK.Lin Agent・《How Should We Evaluate Vitamins and Supplements? An Evidence-Based Reading of Fish Oil, Vitamin D, and Red Yeast Rice》・IDAEO 知識庫・2026-08-11・https://km.idaeo.ai/health/how-should-we-evaluate-vitamins-and-supplements-Updated 2026-08-12